Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
MCF 10F
NM
-
Temsirolimus
MTOR
MTOR
12254.144
uM
1.92370
93.31480
-0.2947 -1.0000 0.2830 0.3903
0.8396
1.8842
MCF 10F
NM
-
Topotecan
TOP1
TOP
7872.007
uM
0.22414
0.42287
-0.5750 -0.2639 0.6677 0.5877
0.8723
1.7126
MCF 10F
NM
-
Topotecan
TOP1
TOP
9566.121
uM
0.50890
6.38250
-0.6225 -1.0000 0.4344 0.5281
0.9860
2.3089
MCF 10F
NM
-
Topotecan
TOP1
TOP
7488.078
uM
0.05315
0.94334
-0.7292 -1.0000 0.3820 0.7796
0.9927
1.5130
MCF 10F
NM
-
Torkinib
15393.211
uM
0.0020
0.00328
-0.1907 -0.1572 0.5522 0.8375
0.9925
1.6449
MCF 10F
NM
-
Tozasertib
AURK/FLT3/ABL/JAK2
AURK
12254.16
uM
8.0680
8.73180
-0.1701 -0.1770 3.8335 0.0845
0.9915
1.4029
MCF 10F
NM
-
TPCA-1
IKK
NFKB
7486.1
uM
6.33670
8.20350
-0.3011 -0.2912 1.7776 0.2506
0.9936
1.0281
MCF 10F
NM
-
Trametinib
MEK
MAPK
7488.05
uM
0.00327
0.00485
-0.3028 -0.2479 1.0200 0.8010
0.9782
1.3218
MCF 10F
NM
-
Trametinib
MEK
MAPK
7871.05
uM
0.00704
0.00891
-0.1722 -0.1373 1.0316 0.6760
0.9917
1.2892
MCF 10F
NM
-
Trametinib
MEK
MAPK
7872.05
uM
0.01741
0.01676
0.0286 0.0236 1.2607 0.5109
0.9925
1.4902
MCF 10F
NM
-
Trametinib
MEK
MAPK
9566.012
uM
0.01217
0.01213
-0.0215 0.0027 1.6371 0.5555
0.9954
2.2335
MCF 10F
NM
-
Trastuzumab
HER2
ErbB
9566.026
uM
inf
inf
0.9681 0.9681 0.0000 -0.0233
-0.7310
2.1367
MCF 10F
NM
-
Trastuzumab
HER2
ErbB
7487.102
uM
5.78510
28.60730
0.4084 -1.0000 0.6873 0.0988
0.8554
1.5273
MCF 10F
NM
-
Trichostatin A
HDAC
HDAC
7486.065
uM
52.68520
91.22780
-0.9164 -0.9036 1.8800 0.5652
0.9979
1.1517
MCF 10F
NM
-
Triciribine
AKT
AKT
7487.074
uM
0.02502
0.18177
-0.6575 -0.7864 0.4765 0.7450
0.9603
1.4197
MCF 10F
NM
-
Valproic acid
HDAC
HDAC
12254.143
uM
702.26870
1000.00000
-0.9090 -0.2550 1.1661 0.1906
0.6277
1.4110
MCF 10F
NM
-
Vinorelbine
TUBB
TUBB
7872.042
uM
0.01453
0.01729
-0.8594 -0.1474 1.4830 0.6638
0.7593
1.3632
MCF 10F
NM
-
Vinorelbine
TUBB
TUBB
7871.018
uM
0.01164
0.01491
-0.9072 -0.2725 1.7569 0.7399
0.8517
1.1973
MCF 10F
NM
-
Vorinostat
HDAC
HDAC
7486.065
uM
702.86880
1000.00000
-0.8187 -0.6947 2.4705 0.3401
0.9903
1.1517
MCF 10F
NM
-
XRP44X
ELK3
MAPK
12254.157
uM
inf
2.29620
0.7352 0.7614 1.2234 0.0586
0.9093
1.6969
MCF 10F
NM
-
Z-Leu-Leu-Norvalinal
Proteasome
Proteasome
14161.189
uM
0.23276
0.47348
-0.9169 -0.9512 1.5006 0.7755
0.9969
1.1003
MCF 10F
NM
-
ZM-447439
AURK
AURK
12254.16
uM
inf
2.36150
0.5734 0.7090 5.0000 0.0457
0.7984
1.4029
MCF12A
NM
Basal B
(Z)-4-Hydroxytamoxifen
ESR1
7491.016
uM
1.54520
1.21350
0.1999 0.3506 5.0000 0.3099
0.7006
0.6625
MCF12A
NM
Basal B
(Z)-4-Hydroxytamoxifen
ESR1
7873.016
uM
14.21690
20.24340
-0.8431 -0.8481 2.8065 0.3039
0.9986
2.1516
MCF12A
NM
Basal B
17-AAG
HSP90
HSP90
10061.037
uM
0.03509
0.03844
-0.6495 -0.2882 5.0000 0.8377
0.6366
1.7478